The Big Development In offices from New York to Nairobi, a curious pattern is emerging: professionals are doing more work in ...

How close are we to the sci-fi vision of autonomous humanoid robots? I visited 11 companies in five Chinese cities to find out ...

As a reminder, today's earnings release, presentation, and statements made during this call include forward-looking statements under federal securities laws. Initial price is always important, but ...

Gabelli Funds Annual Specialty Chemicals Symposium March 19, 2026 1:30 PM EDTCompany ParticipantsWilliam Whitaker - Senior VP, CFO ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but rather ...